Notice is hereby given that the 112th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3, Level 34 North Tower, 80 Collins Street, Melbourne 3000 and online via Microsoft Teams, on Thursday, the 17th of October 2024 at 11:00am AEDT when the attendance of members is requested.
Ordinary Business
1.To confirm the Minutes of the preceding Annual General Meeting which took place on the 19th of October 2023.
2.To receive and consider and deal with the Financial Statements and Statutory Reports for the year ended 30th June 2024.
3.To confirm the election of Directors duly elected in accordance with Clause 17 of the Constitution.
- 3.1 Gilbert Yeates from the State of Queensland has reached the maximum permissible tenure in accordance with Clause 17 and will not be standing for re-election.
- 3.2 Michelle Bou-Samra from the State of Queensland in accordance with Clause 17 and being eligible has offered herself for election.
- 3.3 Patrick Murphy from the State of Queensland in accordance with Clause 17 and being eligible has offered himself for election.
- 3.4 Lakis Zeniou from the State of Queensland in accordance with Clause 17 and being eligible has offered himself for election.
- 3.5 Bruce Elliot from the State of Queensland in accordance with Clause 17 and being eligible has offered himself for election.
- 3.6 Treasure McGuire from the State of Queensland in accordance with Clause 17 and being eligible has offered herself for election.
- 3.7 Ian Todd from the State of South Australia and the Northern Territory retires in accordance with Clause 17 and being eligible has offered himself for re-election.
- 3.8 Paula Kwan from the State of South Australia and the Northern Territory in accordance with Clause 17 and being eligible has offered herself for election.
4.To fix the remuneration of the Directors.
Other Business
To transact any business which, under the Corporations Act 2001 or the Constitution, is required to be transacted at an Annual General Meeting.
Proxies
An eligible member who is entitled to vote but is unable to attend the meeting can appoint a proxy to attend and vote. That person need not be a member of the Company but should be a natural person over the age of 18 years. Proxy forms may be downloaded from the PDL website. Completed, signed Proxy forms must be lodged at the Registered Office of the Company by 11am Monday, 14th October 2024. Proxy forms to be emailed to julie.michel@pdl.org.au or the original to be mailed to PDL, Suite 3, Level 34 North Tower, 80 Collins Street, Melbourne 3000.
Virtual participation
If you would like to attend the meeting online, please contact julie.michel@pdl.org.au so that we can send you a meeting invitation.
Annual Report
The PDL 2024 Annual Report will be available on the PDL website from Thursday 26th September. Please be advised this will only be provided in hard copy upon written/emailed request.
Yours faithfully,
Glen Oliver
Company Secretary
Pharmaceutical Defence Limited
